Checked
To be discontinued
Glycopyrrolate Injection Shortage
FDA drug shortage list
- Status
- To be discontinued
- Products listed
- 4
- 0 unavailable
- Discontinuation date
- 07/30/2026
- First posted
- 07/30/2026
Products and availability
Each strength and package as posted by FDA
Swipe the table sideways to see more columns.
| Product | Availability | Company | Updated |
|---|---|---|---|
| Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)To be discontinued | Not reported | Fresenius Kabi USA, LLC | 07/30/2026 |
| Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)To be discontinued | Not reported | Fresenius Kabi USA, LLC | 07/30/2026 |
| Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)To be discontinued | Not reported | Fresenius Kabi USA, LLC | 07/30/2026 |
| Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)To be discontinued | Not reported | Fresenius Kabi USA, LLC | 07/30/2026 |
Reason and notes
As reported to FDA
- Discontinuation of the manufacture of the drug
Drug information
Labels from the same products
Frequently asked questions
- Is there a glycopyrrolate injection shortage?
- FDA lists Glycopyrrolate Injection as being discontinued by Fresenius Kabi USA, LLC.
- Which companies make the affected glycopyrrolate injection products?
- Fresenius Kabi USA, LLC is listed for the affected products.
- Where does the drug shortage list come from?
- It comes from FDA's drug shortage database through openFDA. Manufacturers report shortages and discontinuations to FDA, and FDA posts each affected product presentation with its availability and the company's contact information.
- What should I do if my medicine is in shortage?
- Talk to your pharmacist or doctor before you change anything. Other strengths, forms or manufacturers may be available, and pharmacists can often help find a substitute. Do not stop taking a medicine on your own.
Source: U.S. Food and Drug Administration, openFDA drug shortages · Last updated 10/26/2026 · Not medical advice